Ramsey, Scott D <br/><br/>
Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes.  [electronic resource] 

 -  Contemporary clinical trials  Jan 2013 
 - 1-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, American Recovery and Reinvestment Act; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1559-2030 
<br/><br/><label>Standard No.: </label>10.1016/j.cct.2012.09.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--genetics<br/>Clinical Trials, Phase III as Topic<br/>Combined Modality Therapy<br/>Female<br/>Humans<br/>Lymph Nodes--pathology<br/>Lymphatic Metastasis<br/>Randomized Controlled Trials as Topic--methods